Novavax’s COVID-19 booster authorized in Canada

0
8

Shares of Novavax Inc. NVAX, -1.25% were up 2.4% in premarket trading on Friday after the company said its COVID-19 booster was authorized for adults in Canada who were previously immunized with Novavax’s protein-based vaccine. The company’s stock is down 85.4% this year, while the S&P 500 SPX, +0.48% has declined 17.2%.

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleFoot Locker shares jump as athletic apparel retailer lifts outlook
Next articleTyson recalls 93,000 pounds of contaminated beef

LEAVE A REPLY

Please enter your comment!
Please enter your name here